FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

September 22, 2025 / Swedan Margen /




Food and Drug Administration Commissioner Dr. Martin A. Makary announced that the FDA is filing a federal register notice to change the label on Leucovorin, so it can be prescribed to treat children with autism.



Source link

Posted in

Swedan Margen

I focus on highlighting the latest in business and entrepreneurship. I enjoy bringing fresh perspectives to the table and sharing stories that inspire growth and innovation.

Leave a Comment